Philippines - English - FDA (Food And Drug Administration)

gpc geo pharma corporation - multivitamins , minerals , panax ginseng c.a. meyer (korean ginseng) , royal jelly - softgel capsule - each softgel capsule contains: retinol palmitate (vitamin a) (eq. to 2.5 mg retinol palmitate) thiamine nitrate (vitamin b) riboflavin (vitamin b2) nicotinamide (vitamin b3) calcium pantothenate (vitamin bs) pyridoxine hydrochloride (vitamin b6) cyanocobalamin (vitamin b12) ascorbic acid (vitamin c) ergocalciferol (vitamin d) (eq. to 10 mcg ergocalciferol) dl-alpha-tocopherol acetate (vitamin e) (eq. to 45 mg dl-alpha-tocopherol acetate) ferrous fumarate (eq. to 9 mg elemental iron) 18 mg 2,500 iu copper sulfate pentahydrate (eq. to 2 mg elemental copper) 2 mg magnesium oxide 2 mg (eq. to 40 mg elemental magnesium) 20 mg zinc oxide 30 mg (eq. to 4 mg elemental zinc) 2 mg potassium sulfate 6 mcg (eq. to 4 mg clemental potassium) 100 mg manganese sulfate monohydrate 400 iu (eq. to 0.98 mg elemental manganese) anhydrous dibasic calcium phosphate 50 iu (eq. to 72 mg elemental calcium) korean ginseng extract (panax ginseng 27.38 mg ca meyer) royal jelly 3 mg 243.14 mg 50 mg 10 mg

United States - English - NLM (National Library of Medicine)

unit dose services - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate tablet is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate.  animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women.  patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] .  maintenance of normal serum calcium levels is important for maternal and fetal well being.  hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism.  calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are

United States - English - NLM (National Library of Medicine)

a-s medication solutions - calcium gluconate (unii: sqe6vb453k) (calcium cation - unii:2m83c4r6zb) - calcium gluconate 94 mg in 1 ml - calcium gluconate injection, usp is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany, hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy.  it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets, osteomalacia, lead colic and magnesium sulfate overdosage.  calcium gluconate has also been employed to decrease capillary permeability in allergic conditions, nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs.  in hyperkalemia, calcium gluconate may aid in antagonizing the cardiac toxicity, provided the patient is not receiving digitalis therapy. calcium salts are contraindicated in patients with ventricular fibrillation or hypercalcemia.  intravenous administration of calcium is contraindicated when serum calcium levels are above normal.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - vitamin a, vitamin d3, vitamin c, vitamin b1, vitamin b2, vitamin b6, vitamin b12, vitamin pp, folic acid, vitamin b5, vitamin e, calcium hydrophosphate dihydrate, ferrous fumarate, copper sulfate pentahydrate, zinc sulfate heptahydrate, magnesium lactate dihydrate, manganese sulfate monohydrate, sodium molybdate dihydrate - tablets coated - 2,94mg+ 0,2mg+ 60mg+ 1mg+ 1,2mg+ 2mg+ 3mcg+ 13mg+ 0,4mg+ 5mg+ 10mg+ 64,5mg+ 30,3mg+ 4mg+ 13,3mg+ 200mg+ 3,1mg+ 0,22mg

Australia - English - Department of Health (Therapeutic Goods Administration)

prescribed investments pty ltd - calcium pantothenate, quantity: 6.55 mg (equivalent: pantothenic acid, qty 6 mg; equivalent: calcium, qty 550 microgram); potassium chloride, quantity: 95.33 mg (equivalent: potassium, qty 50 mg); ferrous fumarate, quantity: 44.83 mg (equivalent: iron, qty 14 mg); zinc oxide, quantity: 12.45 mg (equivalent: zinc, qty 10 mg); manganese sulfate monohydrate, quantity: 6.15 mg (equivalent: manganese, qty 2 mg); cupric sulfate pentahydrate, quantity: 3.93 mg (equivalent: copper, qty 1 mg); heavy magnesium oxide, quantity: 172.74 mg (equivalent: magnesium, qty 100 mg); folic acid, quantity: 200 microgram; cyanocobalamin, quantity: 2.5 microgram; biotin, quantity: 50 microgram; sodium selenite, quantity: 120.5 microgram (equivalent: selenium, qty 55 microgram); chromium picolinate, quantity: 321.8 microgram (equivalent: chromium, qty 40 microgram); sodium molybdate dihydrate, quantity: 127.9 microgram (equivalent: molybdenum, qty 50 microgram); potassium iodide, quantity: 196.2 microgram (equivalent: iodine, qty 150 microgram; equivalent: potassium, qty 46.2 microgram); d-alpha-tocopheryl acid succinate, quantity: 12 mg; ascorbic acid, quantity: 80 mg; thiamine hydrochloride, quantity: 1.23 mg (equivalent: thiamine, qty 1.1 mg); riboflavin, quantity: 1.4 mg; nicotinamide, quantity: 16 mg; pyridoxine hydrochloride, quantity: 1.7 mg (equivalent: pyridoxine, qty 1.4 mg); calcium carbonate, quantity: 127.77 mg (equivalent: calcium, qty 51.1 mg); calcium hydrogen phosphate dihydrate, quantity: 333.33 mg (equivalent: calcium, qty 77.5 mg; equivalent: phosphorus, qty 60 mg); retinol acetate, quantity: 0.9435 mg (equivalent: vitamin a, qty 0.7999 mg); colecalciferol, quantity: 0.005 mg; phytomenadione, quantity: 0.075 mg - tablet, film coated - excipient ingredients: povidone; silicon dioxide; microcrystalline cellulose; crospovidone; croscarmellose sodium; magnesium stearate; hypromellose; macrogol 400; carnauba wax; ethylcellulose; maltodextrin; maize starch; acacia; dl-alpha-tocopherol; spray-dried glucose syrup; sodium ascorbate; d-alpha-tocopherol; fractionated coconut oil; liquid glucose; sucrose - antioxidant/reduce free radicals formed in the body ; helps enhance/promote collagen formation ; maintain/support energy production ; relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support general health and wellbeing ; maintain/support bone health ; aid/assist healthy red blood cell production ; maintain/support healthy cardiovascular system function ; maintain/support immune system health ; aid/assist/helps metabolism of (state vitamin/mineral/nutrient) ; decrease/reduce/relieve symptoms of stress ; maintain/support cognitive function/mental function ; maintain/support nervous system function ; maintain/support healthy pregnancy ; helps enhance/promote skin health

Australia - English - Department of Health (Therapeutic Goods Administration)

sigma company limited - zinc oxide, quantity: 9.336 mg (equivalent: zinc, qty 7.5 mg); ferrous fumarate, quantity: 13.029 mg (equivalent: iron, qty 4 mg); nicotinamide, quantity: 15 mg; calcium pantothenate, quantity: 10.8 mg; colecalciferol, quantity: 15 microgram; ascorbic acid, quantity: 90 mg; pyridoxine hydrochloride, quantity: 11.79 mg (equivalent: pyridoxine, qty 9.7 mg); biotin, quantity: 45 microgram; cyanocobalamin, quantity: 25 microgram; folic acid, quantity: 300 microgram; betacarotene, quantity: 1.8 mg; dl-alpha-tocopheryl acetate, quantity: 111.75 mg; heavy magnesium oxide, quantity: 82.919 mg (equivalent: magnesium, qty 50 mg); chromic chloride hexahydrate, quantity: 513 microgram (equivalent: chromium, qty 100 microgram); potassium iodide, quantity: 196 microgram (equivalent: iodine, qty 150 microgram); calcium carbonate, quantity: 499.5 mg (equivalent: calcium, qty 200 mg); cupric sulfate pentahydrate, quantity: 3.929 mg (equivalent: copper, qty 1 mg); manganese sulfate monohydrate, quantity: 15.38 mg (equivalent: manganese, qty 5 mg); potassium sulfate, quantity: 178.253 mg (equivalent: potassium, qty 80 mg); riboflavin, quantity: 3.2 mg; thiamine nitrate, quantity: 2.689 mg (equivalent: thiamine, qty 2.18 mg); lutein, quantity: 500 microgram; phytomenadione, quantity: 25 microgram; retinol acetate, quantity: 344.1 microgram (equivalent: vitamin a, qty 300 re); lycopene, quantity: 600 microgram; sodium selenate, quantity: 124.8 microgram (equivalent: selenium, qty 52 microgram) - tablet, film coated - excipient ingredients: maltodextrin; titanium dioxide; potato starch; maize starch; microcrystalline cellulose; butylated hydroxytoluene; purified talc; iron oxide black; dl-alpha-tocopherol; hypromellose; magnesium stearate; maize oil; starch sodium octenyl succinate; gelatin; croscarmellose sodium; dl-alpha-tocopheryl acetate; hydrolysed maize starch; purified water; butylated hydroxyanisole; macrogol 400; medium chain triglycerides; sucrose; silicon dioxide; sodium ascorbate; colloidal anhydrous silica - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support eye health ; maintain/support general health and wellbeing ; maintain/support bone health ; maintain/support immune system health ; maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - calcium polystyrene sulfonate, quantity: 999.3 mg/g - powder - excipient ingredients: vanillin; saccharin - calcium resonium is an ion-exchange resin. it is recommended for the treatment of hyperkalaemia associated with anuria and severe oliguria.,it is also used to treat hyperkalaemia in patients requiring dialysis and in patients on regular haemodialysis or on prolonged peritoneal dialysis.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - calcium folinate pentahydrate 12.71 mg/ml equivalent to 10 mg/ml folinic acid - concentrate for injection - 10 mg/ml - active: calcium folinate pentahydrate 12.71 mg/ml equivalent to 10 mg/ml folinic acid excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - · as rescue therapy to reduce toxicity following high-dose methotrexate therapy. · has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions · overdosage of methotrexate and in impaired methotrexate elimination · reducing the toxicity and circumventing the effect of folic acid antagonists

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g);  ;   - powder for oral solution - 1.7 meq/g - active: calcium polystyrene sulfonate 99.93% (binding capacity 1.7meq/g)     excipient: saccharin vanillin

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - calcium gluconate - solution for injection - calcium gluconate 0.94 g / 10 ml - calcium gluconate - calcium gluconate - treatment of acute symptomatic hypocalcaemia.